[go: up one dir, main page]

MX2009003065A - Formulacion efervescente de ibuprofeno con alto indice de disolucion y proceso para su preparacion. - Google Patents

Formulacion efervescente de ibuprofeno con alto indice de disolucion y proceso para su preparacion.

Info

Publication number
MX2009003065A
MX2009003065A MX2009003065A MX2009003065A MX2009003065A MX 2009003065 A MX2009003065 A MX 2009003065A MX 2009003065 A MX2009003065 A MX 2009003065A MX 2009003065 A MX2009003065 A MX 2009003065A MX 2009003065 A MX2009003065 A MX 2009003065A
Authority
MX
Mexico
Prior art keywords
ibuprofen
production
dissolution rate
high dissolution
effervescent preparation
Prior art date
Application number
MX2009003065A
Other languages
English (en)
Inventor
Peter Gruber
Hubert Keck
Original Assignee
Losan Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Losan Pharma Gmbh filed Critical Losan Pharma Gmbh
Publication of MX2009003065A publication Critical patent/MX2009003065A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulaciones efervescentes de ibuprofeno, que contienen (a) un gránulo que contiene ingrediente activo que contiene una sal de ibuprofeno soluble en agua y un excipiente básico, y (b) un gránulo efervescente que contiene un componente ácido y un componente que forma dióxido de carbono, y un proceso para su preparación.
MX2009003065A 2006-09-26 2007-08-30 Formulacion efervescente de ibuprofeno con alto indice de disolucion y proceso para su preparacion. MX2009003065A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06121278A EP1905428A1 (de) 2006-09-26 2006-09-26 Ibuprofen-Brausezubereitung mit hoher Lösungsgeschwindigkeit und Verfahren zu deren Herstellung
PCT/EP2007/059043 WO2008037555A1 (de) 2006-09-26 2007-08-30 Ibuprofen-brausezuberξitung mit hoher lösungsgeschwindigkeit und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
MX2009003065A true MX2009003065A (es) 2009-05-28

Family

ID=37775689

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003065A MX2009003065A (es) 2006-09-26 2007-08-30 Formulacion efervescente de ibuprofeno con alto indice de disolucion y proceso para su preparacion.

Country Status (22)

Country Link
US (1) US20100172981A1 (es)
EP (2) EP1905428A1 (es)
JP (1) JP2010504366A (es)
KR (1) KR20090074784A (es)
CN (1) CN101534797B (es)
AT (1) ATE438387T1 (es)
AU (1) AU2007302161A1 (es)
BR (1) BRPI0717084A2 (es)
CA (1) CA2664420A1 (es)
CO (1) CO6180421A2 (es)
DE (1) DE502007001262D1 (es)
DK (1) DK2061436T3 (es)
EC (1) ECSP099200A (es)
ES (1) ES2331438T3 (es)
IL (1) IL197309A0 (es)
MX (1) MX2009003065A (es)
NZ (1) NZ575183A (es)
PL (1) PL2061436T3 (es)
PT (1) PT2061436E (es)
RU (1) RU2478381C2 (es)
WO (1) WO2008037555A1 (es)
ZA (1) ZA200901478B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1863460B1 (en) 2005-03-22 2013-01-16 Losan Pharma GmbH Solubilized ibuprofen
KR101683293B1 (ko) * 2009-06-29 2016-12-06 라이온 가부시키가이샤 경구용 조성물
JP5663238B2 (ja) * 2009-08-31 2015-02-04 ライオン株式会社 内服固形製剤及びその製造方法
CN102100686A (zh) * 2009-12-21 2011-06-22 北京润德康医药技术有限公司 一种含有布洛芬与精氨酸的药用组合物及其制备方法、用途
CN102743366B (zh) * 2012-07-16 2013-11-20 海南葫芦娃制药有限公司 对乙酰氨基酚泡腾颗粒及其鉴别方法
BR112017005362A2 (pt) 2014-09-17 2018-01-23 Steerlife India Private Ltd composição, forma de dosagem sólida oral, processo para preparação de grânulos efervescentes porosos, processador de parafuso duplo, e, grânulos efervescentes porosos.
WO2017098481A1 (en) 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
FR3055800B1 (fr) 2016-09-15 2020-06-26 Unither Pharmaceuticals Composition solide a ingestion rapide et deglutition facilitee, sous forme de particules solides non agglomerees, comprenant deux differents types de particules
JP6836375B2 (ja) * 2016-11-21 2021-03-03 花王株式会社 口腔内発泡製剤及びその製造法
GB2595301B (en) * 2020-05-21 2025-01-08 Reckitt Benckiser Health Ltd Novel Formulation
GB2595300B (en) * 2020-05-21 2024-03-27 Reckitt Benckiser Health Ltd Novel Formulation
GB2595453B (en) * 2020-05-21 2024-04-03 Reckitt Benckiser Health Ltd Novel Formulation
US20230292992A1 (en) * 2022-03-18 2023-09-21 CapsoVision, Inc. Apparatus for Thermally Stable Capsule Endoscope Using Effervescent Formulation for Controlling Balloon Inflation Rate
WO2023182904A1 (ru) * 2022-03-21 2023-09-28 Акционерное Общество "Производственная Фармацевтическая Компания Обновление" Шипучий лекарственный препарат для приготовления раствора, способ его изготовления

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
CH677606A5 (es) * 1988-07-12 1991-06-14 Aesculapius Pharma Sa
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
CH684929A5 (de) * 1992-11-19 1995-02-15 Sipharm Sisseln Ag Ibuprofen-haltige Brausezusammensetzung und ihre Herstellung.
EP0667149A1 (en) * 1994-02-14 1995-08-16 E-PHARMA TRENTO S.p.A. Ibuprofen based effervescent composition
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
DE19606151C2 (de) * 1996-02-20 1999-05-12 Losan Pharma Gmbh Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben
GB9816899D0 (en) * 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
EP1589944B1 (de) * 2003-02-06 2011-11-23 Gebro Pharma GmbH Pharmazeutische zubereitungen und verfahren zu deren herstellung
WO2006002836A1 (de) * 2004-07-01 2006-01-12 Losan Pharma Gmbh Brausezusammensetzungen von einschlafmitteln
EP1863460B1 (en) * 2005-03-22 2013-01-16 Losan Pharma GmbH Solubilized ibuprofen
WO2006120281A1 (en) 2005-05-12 2006-11-16 Perlos Oyj Optical signal processing device

Also Published As

Publication number Publication date
JP2010504366A (ja) 2010-02-12
EP2061436A1 (de) 2009-05-27
AU2007302161A1 (en) 2008-04-03
ATE438387T1 (de) 2009-08-15
ECSP099200A (es) 2009-06-30
DE502007001262D1 (de) 2009-09-17
KR20090074784A (ko) 2009-07-07
EP2061436B1 (de) 2009-08-05
EP1905428A1 (de) 2008-04-02
PT2061436E (pt) 2009-10-30
IL197309A0 (en) 2009-12-24
CN101534797A (zh) 2009-09-16
US20100172981A1 (en) 2010-07-08
RU2009107536A (ru) 2010-11-20
CA2664420A1 (en) 2008-04-03
ZA200901478B (en) 2010-03-31
NZ575183A (en) 2012-03-30
PL2061436T3 (pl) 2009-12-31
CN101534797B (zh) 2012-03-28
ES2331438T3 (es) 2010-01-04
DK2061436T3 (da) 2009-11-02
CO6180421A2 (es) 2010-07-19
BRPI0717084A2 (pt) 2013-10-29
RU2478381C2 (ru) 2013-04-10
WO2008037555A1 (de) 2008-04-03

Similar Documents

Publication Publication Date Title
MX2009003065A (es) Formulacion efervescente de ibuprofeno con alto indice de disolucion y proceso para su preparacion.
WO2008075081A3 (en) Composition and method for detection of demineralisation
TNSN07452A1 (en) Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
WO2003088923A3 (en) Methods of treating ileus
IL185031A0 (en) Method for the preparation of pregabalin and salts thereof
TW200745261A (en) Aqueous dispersions based on nitrocellulose-polyurethane particles
WO2006122223A3 (en) Strategies for delivery of active agents using micelles and particles
MX2010009222A (es) Soluciones farmaceuticas, proceso de preparacion y usos terapeuticos.
WO2008064202A3 (en) Modified-release formulations of calcium receptor-active compounds
WO2006131591A3 (en) An entacapone-containing oral dosage form
WO2007112366A3 (en) Animal product enrichment using resveratrol
WO2008128775A3 (en) Stabilised pharmaceutical composition containing pregabaline
IN2015DN03936A (es)
WO2008003050A3 (en) Gallium nitrate formulations
MX2012006954A (es) Proceso para la preparacion de compuestos quelados.
WO2008051539A3 (en) Processes for preparing palonosetron salts
MY146596A (en) A tablet having improved stability with at least two actives
WO2011131370A8 (en) Melt-granulated fingolimod
WO2006118884A3 (en) Drug delivery devices and related components, systems and methods
WO2011155728A3 (ko) 골다공증 예방 또는 치료용 조성물 및 이의 제조방법
WO2011127244A8 (en) ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECT
MXPA05008902A (es) Soluciones de drogas en mentol.
WO2007098924A3 (de) Zusammensetzung umfassend ein mittel zum stabilisieren von wirkstoffen im trinkwasser und eine brausemischung, verfahren zu deren herstellung und deren verwendung
MX2011006721A (es) Formulacion farmaceutica de fenofibrato nanonizado.
WO2009120844A3 (en) Pharmaceutical compositions comprising insulin sensitizer and insulin secretagogue

Legal Events

Date Code Title Description
FG Grant or registration